1413: "Rods, Cones, and Blindness"
Interesting Things with JC #1413: "Rods, Cones, and Blindness" – The cells that make vision possible are also the ones that fail when blindness strikes. But what if those same cells could help bring sight back?
Curriculum - Episode Anchor
Episode Title: Rods, Cones, and Blindness
Episode Number: #1413
Host: JC
Audience: Grades 9–12, college intro, homeschool, lifelong learners
Subject Area: Biology, Neuroscience, Vision Science
Lesson Overview
By the end of this lesson, students will be able to:
Define the structure and function of rods and cones in the human retina.
Compare how rods and cones contribute differently to vision, including night vision and color perception.
Analyze the causes and impacts of vision disorders such as retinitis pigmentosa and macular degeneration.
Explain emerging scientific approaches like gene therapy and retinal implants for restoring sight.
Key Vocabulary
Retina (reh-TIN-uh): A thin layer at the back of the eye containing light-sensitive cells. Example: "The retina is where rods and cones capture light."
Rhodopsin (roe-DOP-sin): A pigment in rods that reacts to even a single photon of light. Example: "Rhodopsin allows rods to work in extremely low light."
Fovea (FOH-vee-uh): A tiny center region of the retina packed with cones for detailed color vision. Example: "Reading depends on the high cone density in the fovea."
Retinitis Pigmentosa (reh-tin-EYE-tis pig-men-TOE-suh): A genetic disorder causing rods to fail, leading to tunnel vision and night blindness.
Phosphenes (FAHS-feens): Points of light perceived when retinal implants stimulate remaining cells. Example: "Patients using retinal implants report seeing phosphenes."
Narrative Core
Open: The retina is described as a fragile, paper-thin layer of cells that determines how we see.
Info: Rods and cones are introduced with their unique roles—rods for night vision and cones for daytime and color.
Details: Vision disorders like retinitis pigmentosa and macular degeneration illustrate how failures in these cells cause blindness.
Reflection: Advances in science such as gene therapy and retinal implants offer hope for restoring sight.
Closing: "These are interesting things, with JC."
Digital podcast cover for Interesting Things with JC #1413: "Rods, Cones, and Blindness". The title appears in large yellow text against a black background, with the subtitle “A Story Inspired by Dr. Igo” beneath. On the left, neon illustrations depict purple rod cells, colorful cone cell clusters in red, green, and blue, and curved light paths suggesting photon movement. On the right, a shadowed silhouette of a person wearing dark glasses symbolizes blindness.
Transcript
The retina (reh-TIN-uh) is a paper thin layer at the back of your eye. It measures about 200 micrometers thick, which is less than the width of a human hair. On that layer sit two types of cells that decide how you see the world: rods and cones.
Rods are the night workers. Each one contains rhodopsin (roe-DOP-sin), a pigment so sensitive it can react to a single photon (FOE-ton), the smallest particle of light. You have about 120 million rods in each eye, spread mostly around the edges of the retina. That is why they give you wide angle vision, close to 180 degrees, and help you notice motion in the dark. But rods cannot sense color. They only work in shades of gray.
Cones handle the daytime job. There are about 6 million cones in each eye, packed into the fovea (FOH-vee-uh), the tiny center of the retina that is only about 1.5 millimeters wide, roughly the size of a pinhead. Cones come in three types tuned to blue, green, and red. Working together, they let your brain create the full range of color. If one type fails, colors fade. If all fail, vision becomes gray.
When these systems break down, blindness follows. In retinitis pigmentosa (reh-tin-EYE-tis pig-men-TOE-suh), rods fail first, so night vision disappears and sight narrows into a tunnel. In macular degeneration (MACK-you-lar dee-JEN-er-ay-shun), cones in the center die, so faces and detail blur while the edges remain. Both conditions show how fragile this thin sheet of cells really is.
Science is working on ways to restore vision. Gene therapy is being tested to repair faulty genes in rods and cones. Retinal implants, tiny grids of electrodes (ee-LECK-trodes) smaller than a fingernail, can stimulate remaining cells. The brain reads those signals as points of light called phosphenes (FAHS-feens). It is not natural sight, but it is a step out of darkness.
For most of history, blindness was final. Today the very cells that fail, rods and cones, are helping scientists find ways to bring vision back.
These are interesting things, with JC.
Student Worksheet
What is the main difference between rods and cones in terms of light sensitivity?
Why do rods provide wide-angle vision, while cones provide detailed color vision?
Compare retinitis pigmentosa and macular degeneration in terms of which cells fail first.
How does a retinal implant create the sensation of phosphenes?
Creative prompt: Imagine you are a scientist. Write a short paragraph describing your experiment to restore vision using rods or cones.
Teacher Guide
Estimated Time: 45–60 minutes
Pre-Teaching Vocabulary Strategy: Use visual aids of the eye and retina; practice phonetic pronunciations of terms.
Anticipated Misconceptions:
Students may think rods detect color (clarify they only detect light and dark).
Students may confuse fovea with retina as a whole.
Discussion Prompts:
Why is color vision concentrated in the fovea?
How do scientific advances change the way society views blindness?
Differentiation Strategies:
ESL: Use labeled diagrams and bilingual glossaries.
IEP: Provide enlarged text, tactile diagrams, or audio recordings.
Gifted: Encourage research into CRISPR gene editing for retinitis pigmentosa.
Extension Activities:
Research famous blind scientists, musicians, or thinkers.
Investigate how artificial intelligence is used in vision prosthetics.
Cross-Curricular Connections:
Physics: Photons and light detection.
Ethics: Debates on gene therapy and accessibility.
Health Science: Understanding degenerative diseases.
Quiz
Which pigment allows rods to detect even a single photon?
A. Melanin
B. Rhodopsin
C. Hemoglobin
D. Chlorophyll
Answer: BAbout how many rods are in each human eye?
A. 6 million
B. 12 million
C. 120 million
D. 600 million
Answer: CWhat is the function of cones?
A. Detect motion in the dark
B. Provide color and detail vision
C. Widen the field of view
D. Detect sound waves
Answer: BIn retinitis pigmentosa, which cells fail first?
A. Cones
B. Rods
C. Fovea
D. Electrode cells
Answer: BWhat are phosphenes?
A. Cells in the retina
B. Genetic mutations
C. Points of light perceived from stimulation
D. Proteins in cones
Answer: C
Assessment
Explain how rods and cones work together to create a complete picture of the visual world.
Discuss the potential benefits and limitations of using gene therapy and retinal implants to treat blindness.
Rubric:
3: Accurate, complete, and thoughtful explanation with examples.
2: Partial answer with some missing details.
1: Inaccurate or vague explanation.
Standards Alignment
NGSS HS-LS1-2: Students model how specialized cells like rods and cones work together in systems.
NGSS HS-LS1-3: Students analyze feedback mechanisms in vision and sensory response.
CCSS.ELA-LITERACY.RST.9-10.2: Summarize scientific concepts like retinal function.
ISTE 4a: Use technology to investigate and understand retinal implants.
UK AQA Biology GCSE 4.5.2: Structure and function of the eye, including retina and vision.
IB Biology (SL/HL) Topic 3.2: Chromosomes and genetic disorders such as retinitis pigmentosa.
Cambridge IGCSE Biology 2.3: The eye as a sense organ, photoreceptor functions, and common defects.
Show Notes
In this episode, JC explores how rods and cones—the eye’s specialized photoreceptors—create vision by detecting light and color. The episode highlights how their failure can cause blindness through disorders such as retinitis pigmentosa and macular degeneration. Cutting-edge science, from gene therapy to retinal implants, is working to restore sight where it was once permanently lost. This topic is highly relevant for classrooms today as it blends biology, neuroscience, and biomedical engineering, showing students how scientific knowledge can transform human health and redefine what is possible.
References
National Eye Institute. (n.d.). Retinitis pigmentosa. Retrieved from https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/retinitis-pigmentosa
American Academy of Ophthalmology. (2021). Age-related macular degeneration. Retrieved from https://www.aao.org/eye-health/diseases/amd
Song, D. J., Raghuram, V., & Feuer, W. (2022). Mechanism of cone degeneration in retinitis pigmentosa. Frontiers in Neuroscience, 16, Article 11414453. https://pmc.ncbi.nlm.nih.gov/articles/PMC11414453/
Suleman, N., et al. (2025). Current understanding on Retinitis Pigmentosa: A literature review. Frontiers in Ophthalmology, 5. https://www.frontiersin.org/journals/ophthalmology/articles/10.3389/fopht.2025.1600283/full
Narayan, D. S., Wood, J. P., Chidlow, G., & Casson, R. J. (2016). A review of the mechanisms of cone degeneration in retinitis pigmentosa. Acta Ophthalmologica, 94(5), 748–754. https://onlinelibrary.wiley.com/doi/10.1111/aos.13141
Gagliardi, G., et al. (2019). Photoreceptor cell replacement in macular degeneration: Progress and challenges. Progress in Retinal and Eye Research, 69, 116–142. https://www.sciencedirect.com/science/article/abs/pii/S1350946218300910
Kaplan, H. J., et al. (2017). Restoration of cone photoreceptor function in retinitis pigmentosa following rod degeneration. Translational Vision Science & Technology, 6(4), 7. https://tvst.arvojournals.org/article.aspx?articleid=2653515
Carleton, M., et al. (2024). Bridging the gap of vision restoration: Comparison of Retinitis Pigmentosa and Age-Related Macular Degeneration with a focus on restoration strategies. Frontiers in Cellular Neuroscience, 18, Article 1502473. https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2024.1502473/full
Thirunavukarasu, A. J., et al. (2025). Proven and potential endpoints for clinical trials of inherited retinal diseases. Gene Therapy. https://www.nature.com/articles/s41434-025-00552-7